Literature DB >> 22024275

The -omics era: proteomics and lipidomics in vascular research.

Athanasios Didangelos1, Christin Stegemann, Manuel Mayr.   

Abstract

A main limitation of the current approaches to atherosclerosis research is the focus on the investigation of individual factors, which are presumed to be involved in the pathophysiology and whose biological functions are, at least in part, understood. These molecules are investigated extensively while others are not studied at all. In comparison to our detailed knowledge about the role of inflammation in atherosclerosis, little is known about extracellular matrix remodelling and the retention of individual lipid species rather than lipid classes in early and advanced atherosclerotic lesions. The recent development of mass spectrometry-based methods and advanced analytical tools are transforming our ability to profile extracellular proteins and lipid species in animal models and clinical specimen with the goal of illuminating pathological processes and discovering new biomarkers. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22024275     DOI: 10.1016/j.atherosclerosis.2011.09.043

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Aliphatic chain length by isotropic mixing (ALCHIM): determining composition of complex lipid samples by ¹H NMR spectroscopy.

Authors:  Joseph R Sachleben; Ruiyang Yi; Paul A Volden; Suzanne D Conzen
Journal:  J Biomol NMR       Date:  2014-05-15       Impact factor: 2.835

2.  Biomechanical factors in atherosclerosis: mechanisms and clinical implications.

Authors:  Brenda R Kwak; Magnus Bäck; Marie-Luce Bochaton-Piallat; Giuseppina Caligiuri; Mat J A P Daemen; Peter F Davies; Imo E Hoefer; Paul Holvoet; Hanjoong Jo; Rob Krams; Stephanie Lehoux; Claudia Monaco; Sabine Steffens; Renu Virmani; Christian Weber; Jolanda J Wentzel; Paul C Evans
Journal:  Eur Heart J       Date:  2014-09-17       Impact factor: 29.983

3.  Alternative methods for characterization of extracellular vesicles.

Authors:  Fatemeh Momen-Heravi; Leonora Balaj; Sara Alian; John Tigges; Vasilis Toxavidis; Maria Ericsson; Robert J Distel; Alexander R Ivanov; Johan Skog; Winston Patrick Kuo
Journal:  Front Physiol       Date:  2012-09-07       Impact factor: 4.566

Review 4.  Lipidomics in vascular health: current perspectives.

Authors:  Genovefa Kolovou; Vana Kolovou; Sophie Mavrogeni
Journal:  Vasc Health Risk Manag       Date:  2015-06-12

5.  Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis.

Authors:  Friederike Cuello; Manu Shankar-Hari; Ursula Mayr; Xiaoke Yin; Melanie Marshall; Gonca Suna; Peter Willeit; Sarah R Langley; Tamani Jayawardhana; Tanja Zeller; Marius Terblanche; Ajay M Shah; Manuel Mayr
Journal:  Mol Cell Proteomics       Date:  2014-06-23       Impact factor: 5.911

6.  Novel cardiac-specific biomarkers and the cardiovascular continuum.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Athanasios Didangelos; Morten A Karsdal
Journal:  Biomark Insights       Date:  2012-05-02

Review 7.  Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics.

Authors:  Kiersten A Liddy; Melanie Y White; Stuart J Cordwell
Journal:  Genome Med       Date:  2013-02-28       Impact factor: 11.117

Review 8.  Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction.

Authors:  Merry L Lindsey; Michael E Hall; Romain Harmancey; Yonggang Ma
Journal:  Clin Proteomics       Date:  2016-09-15       Impact factor: 3.988

Review 9.  Vascular proteomics in metabolic and cardiovascular diseases.

Authors:  M Lynch; J Barallobre-Barreiro; M Jahangiri; M Mayr
Journal:  J Intern Med       Date:  2016-03-04       Impact factor: 8.989

10.  Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid Atherosclerosis.

Authors:  Santosh D Bhosale; Robert Moulder; Mikko S Venäläinen; Juhani S Koskinen; Niina Pitkänen; Markus T Juonala; Mika A P Kähönen; Terho J Lehtimäki; Jorma S A Viikari; Laura L Elo; David R Goodlett; Riitta Lahesmaa; Olli T Raitakari
Journal:  Sci Rep       Date:  2018-06-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.